EdgarLookup

KIMCO REALTY CORP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that KIMCO REALTY CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
27.3%
Profit Margin
Net income ÷ revenue
3%
Return on Assets
Net income ÷ assets
0.88x
Debt-to-Equity
Total liabilities ÷ equity
+5.1%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.14B Feb 20, 2026
FY2025 Dec 31, 2024 $2.04B Feb 20, 2026
FY2025 Dec 31, 2023 $1.78B Feb 20, 2026
FY2024 Dec 31, 2022 $1.73B Feb 21, 2025
FY2023 Dec 31, 2021 $1.36B Feb 26, 2024
FY2020 Dec 31, 2020 $269.44M Feb 23, 2021
FY2020 Sep 30, 2020 $259.79M Feb 23, 2021
FY2020 Jun 30, 2020 $238.92M Feb 23, 2021
FY2020 Mar 31, 2020 $289.74M Feb 23, 2021
FY2020 Dec 31, 2019 $296.13M Feb 23, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $584.74M Feb 20, 2026
FY2025 Dec 31, 2024 $410.79M Feb 20, 2026
FY2025 Dec 31, 2023 $654.27M Feb 20, 2026
FY2024 Dec 31, 2022 $125.98M Feb 21, 2025
FY2023 Dec 31, 2021 $844.06M Feb 26, 2024
FY2020 Dec 31, 2020 $201.23M Feb 23, 2021
FY2020 Sep 30, 2020 ($38.39M) Feb 23, 2021
FY2020 Jun 30, 2020 $747.89M Feb 23, 2021
FY2020 Mar 31, 2020 $90.10M Feb 23, 2021
FY2020 Dec 31, 2019 $109.42M Feb 23, 2021

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $770.82M Feb 20, 2026
FY2025 Dec 31, 2024 $629.09M Feb 20, 2026
FY2025 Dec 31, 2023 $638.78M Feb 20, 2026
FY2024 Dec 31, 2022 $565.46M Feb 21, 2025
FY2023 Dec 31, 2021 $424.29M Feb 26, 2024
FY2022 Dec 31, 2020 $332.61M Feb 24, 2023
FY2021 Dec 31, 2019 $477.59M Mar 1, 2022
FY2020 Dec 31, 2018 $582.41M Feb 23, 2021
FY2019 Dec 31, 2017 $431.02M Feb 25, 2020
FY2018 Dec 31, 2016 $393.65M Feb 15, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.12B Feb 20, 2026
FY2025 Dec 31, 2024 $1.01B Feb 20, 2026
FY2025 Dec 31, 2023 $1.07B Feb 20, 2026
FY2024 Dec 31, 2022 $861.11M Feb 21, 2025
FY2023 Dec 31, 2021 $618.88M Feb 26, 2024
FY2022 Dec 31, 2020 $589.91M Feb 24, 2023
FY2021 Dec 31, 2019 $583.63M Mar 1, 2022
FY2020 Dec 31, 2018 $637.94M Feb 23, 2021
FY2019 Dec 31, 2017 $614.18M Feb 25, 2020
FY2018 Dec 31, 2016 $592.10M Feb 15, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $18.40M Feb 20, 2026
FY2010 Dec 31, 2010 $251.31M Feb 28, 2011
FY2010 Dec 31, 2009 $955.37M Feb 28, 2011

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $19.69B Feb 20, 2026
FY2025 Dec 31, 2024 $20.31B Feb 20, 2026
FY2024 Dec 31, 2023 $18.27B Feb 21, 2025
FY2023 Dec 31, 2022 $17.83B Feb 26, 2024
FY2022 Dec 31, 2021 $18.46B Feb 24, 2023
FY2021 Dec 31, 2020 $11.61B Mar 1, 2022
FY2020 Dec 31, 2019 $11.00B Feb 23, 2021
FY2019 Dec 31, 2018 $11.00B Feb 25, 2020
FY2018 Dec 31, 2017 $11.76B Feb 15, 2019
FY2017 Dec 31, 2016 $11.23B Feb 23, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $9.12B Feb 20, 2026
FY2025 Dec 31, 2024 $9.46B Feb 20, 2026
FY2024 Dec 31, 2023 $8.55B Feb 21, 2025
FY2023 Dec 31, 2022 $8.09B Feb 26, 2024
FY2022 Dec 31, 2021 $8.34B Feb 24, 2023
FY2021 Dec 31, 2020 $5.93B Mar 1, 2022
FY2020 Dec 31, 2019 $6.05B Feb 23, 2021
FY2019 Dec 31, 2018 $5.56B Feb 25, 2020
FY2018 Dec 31, 2017 $6.23B Feb 15, 2019
FY2017 Dec 31, 2016 $5.74B Feb 23, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $10.39B Feb 20, 2026
FY2025 Dec 31, 2024 $10.65B Feb 20, 2026
FY2024 Dec 31, 2023 $9.53B Feb 21, 2025
FY2023 Dec 31, 2022 $9.52B Feb 26, 2024
FY2022 Dec 31, 2021 $9.90B Feb 24, 2023
FY2021 Dec 31, 2020 $5.61B Mar 1, 2022
FY2020 Dec 31, 2019 $4.86B Feb 23, 2021
FY2019 Dec 31, 2018 $5.33B Feb 25, 2020
FY2018 Dec 31, 2017 $5.39B Feb 15, 2019
FY2017 Dec 31, 2016 $5.26B Feb 23, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($528.73M) Feb 20, 2026
FY2025 Dec 31, 2024 ($398.79M) Feb 20, 2026
FY2024 Dec 31, 2023 ($122.58M) Feb 21, 2025
FY2023 Dec 31, 2022 ($119.55M) Feb 26, 2024
FY2022 Dec 31, 2021 $299.12M Feb 24, 2023

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $211.65M Feb 20, 2026
FY2025 Dec 31, 2024 $688.62M Feb 20, 2026
FY2024 Dec 31, 2023 $780.52M Feb 21, 2025
FY2023 Dec 31, 2022 $146.97M Feb 26, 2024
FY2022 Dec 31, 2021 $325.63M Feb 24, 2023
FY2021 Dec 31, 2020 $292.95M Mar 1, 2022
FY2020 Dec 31, 2019 $123.95M Feb 23, 2021
FY2019 Dec 31, 2018 $143.58M Feb 25, 2020
FY2018 Dec 31, 2017 $238.51M Feb 15, 2019
FY2017 Dec 31, 2016 $142.49M Feb 23, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.72B Feb 20, 2026
FY2025 Dec 31, 2024 $7.96B Feb 20, 2026
FY2024 Dec 31, 2023 $7.26B Feb 21, 2025
FY2023 Dec 31, 2022 $6.78B Feb 26, 2024
FY2022 Dec 31, 2021 $7.03B Feb 24, 2023
FY2021 Dec 31, 2020 $5.04B Mar 1, 2022
FY2020 Dec 31, 2019 $4.83B Feb 23, 2021
FY2019 Dec 31, 2018 $4.38B Feb 25, 2020
FY2018 Dec 31, 2017 $4.60B Feb 15, 2019
FY2016 Dec 31, 2016 $3.93B Feb 27, 2017

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2020 Dec 31, 2020 0 Feb 23, 2021
FY2020 Sep 30, 2020 0 Feb 23, 2021
FY2020 Jun 30, 2020 1 Feb 23, 2021
FY2020 Mar 31, 2020 0 Feb 23, 2021
FY2020 Dec 31, 2019 0 Feb 23, 2021
FY2020 Sep 30, 2019 0 Feb 23, 2021
FY2020 Jun 30, 2019 0 Feb 23, 2021
FY2020 Mar 31, 2019 0 Feb 23, 2021
FY2019 Dec 31, 2018 0 Feb 25, 2020
FY2019 Sep 30, 2018 0 Feb 25, 2020

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2020 Dec 31, 2020 0 Feb 23, 2021
FY2020 Sep 30, 2020 0 Feb 23, 2021
FY2020 Jun 30, 2020 1 Feb 23, 2021
FY2020 Mar 31, 2020 0 Feb 23, 2021
FY2020 Dec 31, 2019 0 Feb 23, 2021
FY2020 Sep 30, 2019 0 Feb 23, 2021
FY2020 Jun 30, 2019 0 Feb 23, 2021
FY2020 Mar 31, 2019 0 Feb 23, 2021
FY2019 Dec 31, 2018 0 Feb 25, 2020
FY2019 Sep 30, 2018 0 Feb 25, 2020

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 674.09M Feb 20, 2026
FY2025 Dec 31, 2024 679.49M Feb 20, 2026
FY2024 Dec 31, 2023 619.87M Feb 21, 2025
FY2023 Dec 31, 2022 618.48M Feb 26, 2024
FY2022 Dec 31, 2021 616.66M Feb 24, 2023
FY2021 Dec 31, 2020 432.52M Mar 1, 2022
FY2020 Dec 31, 2019 431.81M Feb 23, 2021
FY2019 Dec 31, 2018 421.39M Feb 25, 2020
FY2018 Dec 31, 2017 425.65M Feb 15, 2019
FY2017 Dec 31, 2016 425.03M Feb 23, 2018

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 $657.46M Feb 26, 2024
FY2023 Dec 31, 2022 $544.74M Feb 26, 2024
FY2023 Dec 31, 2021 $382.13M Feb 26, 2024
FY2022 Dec 31, 2020 $379.87M Feb 24, 2023
FY2021 Dec 31, 2019 $531.57M Mar 1, 2022
FY2020 Dec 31, 2018 $529.76M Feb 23, 2021
FY2019 Dec 31, 2017 $506.17M Feb 25, 2020
FY2018 Dec 31, 2016 $474.05M Feb 15, 2019
FY2017 Dec 31, 2015 $455.83M Feb 23, 2018
FY2016 Dec 31, 2014 $427.87M Feb 27, 2017